(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 13.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Quanterix's revenue in 2025 is $135,688,000.On average, 2 Wall Street analysts forecast QTRX's revenue for 2025 to be $5,186,052,794, with the lowest QTRX revenue forecast at $5,168,191,277, and the highest QTRX revenue forecast at $5,203,914,312. On average, 2 Wall Street analysts forecast QTRX's revenue for 2026 to be $7,049,086,734, with the lowest QTRX revenue forecast at $6,861,152,506, and the highest QTRX revenue forecast at $7,237,020,963.
In 2027, QTRX is forecast to generate $8,084,278,165 in revenue, with the lowest revenue forecast at $8,084,278,165 and the highest revenue forecast at $8,084,278,165.